Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

SAVA Relative to the S&P 500

SAVA Relative to the Sector

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Cassava Sciences, Inc. (NASD:SAVA) seasonal charts above shows that a Buy Date of July 15 and a Sell Date of October 3 has resulted in a geometric average return of 14.92% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 15 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 35.9% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.

To download SAVA seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: SAVA